Sargent Bickham Lagudis LLC Dexcom Inc Transaction History

Sargent Bickham Lagudis LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$76.35 - $94.18 $916 - $1,130	-12 Reduced 50.0%	12 $1,000
Q2 2022 Jul 13, 2022	BUY	$67.99 - $132.89 $1,427 - $2,790	21 Added 700.0%	24 $2,000
Q4 2021 Jan 18, 2022	BUY	$129.87 - $162.82 $389 - $488	3 New	3 $2,000
Q2 2021 Jul 19, 2021	SELL	$80.99 - $107.93 $2,267 - $3,022	-28 Closed	0 $0
Q1 2021 May 24, 2021	SELL	$84.79 - $104.74 $1,865 - $2,304	-22 Reduced 44.0%	28 $10,000
Q4 2020 May 24, 2021	BUY	$78.0 - $104.5 $1,716 - $2,299	22 Added 78.57%	50 $18,000
Q4 2020 May 24, 2021	BUY	$78.0 - $104.5 $2,184 - $2,926	28 New	28 $10,000

1,021

352M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.